Development Of Anticeramide Treatment As A Novel Medical Countermeasure For Acute Effects Of Radiation Exposure
Award Notice Posted
- Solicitation number
- NIAID-BAA-75N93021R00019
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Ceramedix Holding, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93023C00015 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- New York, New York 10013, United States
Notice details come from SAM.gov. Updated .
About this opportunity
Ceramedix Holding, LLC was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases on July 1, 2023 for $4,321,240 to develop an anticeramide treatment as a novel medical countermeasure for acute effects of radiation exposure over the period of performance. The contract will support Ceramedix Holding, LLC's work in developing this medical countermeasure to address health issues caused by radiation exposure.
Notice text
Awarded contract 75N93023C00015 to Ceramedix Holding, LLC for 4321240.00 on 2023-07-01.
Notice history
10 of 12 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity